Global and Region Clinical Trials Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Clinical Trials market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Clinical Trialsmarket, defines the market attractiveness level of Clinical Trials market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Clinical Trials industry, describes the types of Clinical Trials market, the applications of major players and the market size, and deeply analyzes the current situation of the global Clinical Trials market and the development prospects and opportunities of Clinical Trials industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Clinical Trials market in Chapter 13.

    By Player:

    • IQVIA

    • Eli Lilly and Company

    • ICON Plc

    • Novo Nordisk AS

    • Clinipace

    By Type:

    • Phase I

    • Phase II

    • Phase III

    • Phase IV

    By End-User:

    • Interventional

    • Observational

    • Expanded Access

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Clinical Trials Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Clinical Trials Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Clinical Trials Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Clinical Trials Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Clinical Trials Market Analysis and Outlook to 2022

    • 7.1 Global Clinical Trials Consumption (2017-2022)

    • 7.2 United States Clinical Trials Consumption (2017-2022)

    • 7.3 Europe Clinical Trials Consumption (2017-2022)

    • 7.4 China Clinical Trials Consumption (2017-2022)

    • 7.5 Japan Clinical Trials Consumption (2017-2022)

    • 7.6 India Clinical Trials Consumption (2017-2022)

    • 7.7 South Korea Clinical Trials Consumption (2017-2022)

    8 Region and Country-wise Clinical Trials Market Analysis and Outlook to 2028

    • 8.1 Global Clinical Trials Consumption Forecast (2022-2028)

    • 8.2 United States Clinical Trials Consumption Forecast (2022-2028)

    • 8.3 Europe Clinical Trials Consumption Forecast (2022-2028)

    • 8.4 China Clinical Trials Consumption Forecast (2022-2028)

    • 8.5 Japan Clinical Trials Consumption Forecast (2022-2028)

    • 8.6 India Clinical Trials Consumption Forecast (2022-2028)

    • 8.7 South Korea Clinical Trials Consumption Forecast (2022-2028)

    9 Global Clinical Trials Market Outlook by Types and Applications to 2022

    • 9.1 Global Clinical Trials Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Phase I Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Phase II Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Phase III Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Phase IV Consumption and Growth Rate (2017-2022)

    • 9.2 Global Clinical Trials Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Interventional Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Observational Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Expanded Access Consumption and Growth Rate (2017-2022)

    10 Global Clinical Trials Market Outlook by Types and Applications to 2028

    • 10.1 Global Clinical Trials Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Phase I Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Phase II Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Phase III Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Phase IV Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Clinical Trials Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Interventional Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Observational Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Expanded Access Consumption Forecast and Growth Rate (2022-2028)

    11 Global Clinical Trials Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Clinical Trials Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Clinical Trials Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Clinical Trials Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Clinical Trials Market Competitive Analysis

    • 14.1 IQVIA

      • 14.1.1 IQVIA Company Details

      • 14.1.2 IQVIA Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 IQVIA Clinical Trials Product and Service

    • 14.2 Eli Lilly and Company

      • 14.2.1 Eli Lilly and Company Company Details

      • 14.2.2 Eli Lilly and Company Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Eli Lilly and Company Clinical Trials Product and Service

    • 14.3 ICON Plc

      • 14.3.1 ICON Plc Company Details

      • 14.3.2 ICON Plc Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 ICON Plc Clinical Trials Product and Service

    • 14.4 Novo Nordisk AS

      • 14.4.1 Novo Nordisk AS Company Details

      • 14.4.2 Novo Nordisk AS Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novo Nordisk AS Clinical Trials Product and Service

    • 14.5 Clinipace

      • 14.5.1 Clinipace Company Details

      • 14.5.2 Clinipace Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Clinipace Clinical Trials Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Clinical Trials

    • Figure Clinical Trials Picture

    • Table Global Clinical Trials Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Clinical Trials Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Clinical Trials Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Clinical Trials Consumption by Country (2017-2022)

    • Figure United States Clinical Trials Consumption and Growth Rate (2017-2022)

    • Table Europe Clinical Trials Consumption and Growth Rate (2017-2022)

    • Figure China Clinical Trials Consumption and Growth Rate (2017-2022)

    • Figure Japan Clinical Trials Consumption and Growth Rate (2017-2022)

    • Figure India Clinical Trials Consumption and Growth Rate (2017-2022)

    • Figure South Korea Clinical Trials Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Trials Consumption Forecast by Country (2022-2028)

    • Figure United States Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Clinical Trials Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Phase I Consumption and Growth Rate (2017-2022)

    • Figure Global Phase II Consumption and Growth Rate (2017-2022)

    • Figure Global Phase III Consumption and Growth Rate (2017-2022)

    • Figure Global Phase IV Consumption and Growth Rate (2017-2022)

    • Figure Global Interventional Consumption and Growth Rate (2017-2022)

    • Figure Global Observational Consumption and Growth Rate (2017-2022)

    • Figure Global Expanded Access Consumption and Growth Rate (2017-2022)

    • Figure Global Phase I Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Phase II Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Phase III Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Phase IV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interventional Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Observational Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Expanded Access Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Clinical Trials Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Clinical Trials Export by Region (Top 5 Countries) (2017-2028)

    • Table IQVIA (Foundation Year, Company Profile and etc.)

    • Table IQVIA Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

    • Table IQVIA Clinical Trials Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Clinical Trials Product and Service

    • Table ICON Plc (Foundation Year, Company Profile and etc.)

    • Table ICON Plc Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICON Plc Clinical Trials Product and Service

    • Table Novo Nordisk AS (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk AS Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk AS Clinical Trials Product and Service

    • Table Clinipace (Foundation Year, Company Profile and etc.)

    • Table Clinipace Clinical Trials Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clinipace Clinical Trials Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.